These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 37264930)
1. Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases. Zhao L; Song J; Du Y; Ren C; Guo B; Bi H Drug Deliv; 2023 Dec; 30(1):2219419. PubMed ID: 37264930 [TBL] [Abstract][Full Text] [Related]
2. A review on therapeutic contact lenses for ocular drug delivery. Maulvi FA; Soni TG; Shah DO Drug Deliv; 2016 Oct; 23(8):3017-3026. PubMed ID: 26821766 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive review on contact lens for ophthalmic drug delivery. Xu J; Xue Y; Hu G; Lin T; Gou J; Yin T; He H; Zhang Y; Tang X J Control Release; 2018 Jul; 281():97-118. PubMed ID: 29782944 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses. Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359 [TBL] [Abstract][Full Text] [Related]
9. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses. Tashakori-Sabzevar F; Mohajeri SA Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses. Hsu KH; Fentzke RC; Chauhan A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):531-40. PubMed ID: 23665502 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic contact lenses for ophthalmic drug delivery: major challenges. Zhang X; Cao X; Qi P J Biomater Sci Polym Ed; 2020 Mar; 31(4):549-560. PubMed ID: 31902299 [TBL] [Abstract][Full Text] [Related]
12. Soft Contact Lenses as Drug Delivery Systems: A Review. Rykowska I; Nowak I; Nowak R Molecules; 2021 Sep; 26(18):. PubMed ID: 34577045 [TBL] [Abstract][Full Text] [Related]
13. Review of ocular drug delivery. Sultana Y; Jain R; Aqil M; Ali A Curr Drug Deliv; 2006 Apr; 3(2):207-17. PubMed ID: 16611007 [TBL] [Abstract][Full Text] [Related]
14. Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation. Yang H; Zhang F; Fan Y; Zhang J; Fang T; Xing D; Zhen Y; Nie Z; Liu Y; Wang D; Li J Pharm Res; 2024 Mar; 41(3):531-546. PubMed ID: 38366235 [TBL] [Abstract][Full Text] [Related]
15. Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics. Chaudhari P; Ghate VM; Lewis SA Eur J Pharm Biopharm; 2021 Apr; 161():80-99. PubMed ID: 33607239 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery. Abdi B; Mofidfar M; Hassanpour F; Kirbas Cilingir E; Kalajahi SK; Milani PH; Ghanbarzadeh M; Fadel D; Barnett M; Ta CN; Leblanc RM; Chauhan A; Abbasi F Int J Pharm; 2023 May; 638():122740. PubMed ID: 36804524 [TBL] [Abstract][Full Text] [Related]
17. Poly(2-hydroxyethyl methacrylate)/β-cyclodextrin-hyaluronan contact lens with tear protein adsorption resistance and sustained drug delivery for ophthalmic diseases. Li R; Guan X; Lin X; Guan P; Zhang X; Rao Z; Du L; Zhao J; Rong J; Zhao J Acta Biomater; 2020 Jul; 110():105-118. PubMed ID: 32339710 [TBL] [Abstract][Full Text] [Related]